Acute Partial Thickness Burn Study Comparing Transforming Powder Dressing to Standard of Care Dressing

Part of paid clinical trials in Orange, California.

Sponsor
ULURU Inc.
Study ID
NCT05424354
Phase
PHASE4
Status
Recruiting

Conditions

  • Wounds and Injuries

Eligibility Criteria

Sex
ALL
Age
18 Years - 65 Years
Healthy Volunteers
Accepted

Interventions

  • Altrazeal (R) Transforming Powder Dressing — DEVICE
    After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with Altrazeal TPD.
  • Standard of Care burn dressing — OTHER
    After informed consent and the subject is determined to meet all selection criteria, randomization will occur in a 1:1 ratio, to determine the treatment arm of the study. Half of those randomized will receive burn care with the institution's standard of care burn dressing.

Study Details

This study is being performed to assess the effectiveness of Altrazeal(R) Transforming Powder Dressing (TPD) in patients with partial thickness burns compared to the current standard of care (SOC) dressing. Adult men and women 18-65 years old who are hospitalized with an acute (meaning the burn injury occurred less than 72 hours prior to enrollment in the study) partial thickness burn wound, less than 20 percent of total body surface area may be considered. Subjects will be randomized in a 1:1 ratio to either SOC or TPD. Subjects will be followed for up to 28 days after enrollment.

Key Dates

Start date
May 26, 2022
Status verified
Nov 2025
Primary completion
Jun 30, 2026
Completion
Sep 30, 2026

Study Design

Enrollment
60 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Transforming Powder Dressing
    Half of the subjects will be randomized to Transforming Powder Dressing (TPD) to treat the burn wound(s). Subjects will be evaluated on Treatment Day 0, 3, 7, 10, 14, 21, and 28 (or sooner if the wound heals prior to end of study visit on Day 28). On each study visit, wound care will be performed. TPD will be applied directly on the burn wound, followed by another dressing (often called a secondary dressing).
  • Active Comparator: Standard of Care Dressing
    Half of the subjects will be randomized to Standard of Care (SOC) to treat the burn wound(s). Subjects will be evaluated on Treatment Day 0, 3, 7, 10, 14, 21, and 28 (or sooner if the wound heals prior to end of study visit on Day 28). On each study visit, wound care will be performed. The standard of care burn dressing will be applied directly on the burn wound, followed by another dressing (often called a secondary dressing).

Primary Outcome Measure

Pain from the Burn Wound [ Time Frame: 28 days (or sooner if the wound heals prior to 28 days) ]

Central Contacts

Locations (6)

FacilityCityStateZIPSite coordinators
University of California-IrvineOrangeCalifornia92868
Lizette Spears
714-456-5840
Taina Aruju
714-456-5840
Victor Joe, MD (PRINCIPAL_INVESTIGATOR)
Theresa Chin, MD (SUB_INVESTIGATOR)
Kimberly Burton, PA (SUB_INVESTIGATOR)
MedStar Washington Hospital CenterWashington D.C.District of Columbia20010
Mary (Abby) Bellon
202 877 3519
Jeffrey Shupp, MD (PRINCIPAL_INVESTIGATOR)
Jackson Memorial Hospital UM/JMH Burn CenterMiamiFlorida33136
Lisa Otero, BA
305-585-1348
Carl I Schulman, MD (PRINCIPAL_INVESTIGATOR)
Joyce I Kaufman, MD (SUB_INVESTIGATOR)
Louis R Pizano, MD (SUB_INVESTIGATOR)
Shevonne S Satahoo, MD (SUB_INVESTIGATOR)
University of Louisville HealthLouisvilleKentucky40202
Madison Rutledge
(502) 629-3327
Michelle Broers
Matthew Bozeman, MD (PRINCIPAL_INVESTIGATOR)
Westchester Medical CenterValhallaNew York10595
Daniela Santamaria-Vargas, MSc
9144931528
Falyn Katzman, MPH
Joseph Turkowski, MD (PRINCIPAL_INVESTIGATOR)
Maryana Koshyk, PA-C (SUB_INVESTIGATOR)
Rachelle Lodescar, MD (SUB_INVESTIGATOR)
University of Texas SW (Parkland)DallasTexas75235
Scarlett Dwyer
214 645-0445
Caroline Park, MD (PRINCIPAL_INVESTIGATOR)
Chiaka Akarichi, MD (SUB_INVESTIGATOR)
Rebecca Coffey, PhD (SUB_INVESTIGATOR)

Find similar trials in Orange, CA

Related Studies